Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies

Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies

Hyperhomocysteinemia is recognized as a risk factor for several diseases, including cardiovascular and neurological conditions. Homocysteine (HCys) is a key metabolite involved in the biosynthesis and metabolism of methionine (Met), which plays a pivotal role in the physiological cell's life cy...

Full description

Bibliographic Details
Main Authors: Caterina Tinelli, Antonella Di Pino, Elena Ficulle, Serena Marcelli, Marco Feligioni
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Nutrition
Subjects:
hyperhomocysteinemia
neurological diseases
nutraceuticals
Normocis
cardiovascular
Alzheimer
Online Access:https://www.frontiersin.org/article/10.3389/fnut.2019.00049/full

Internet

https://www.frontiersin.org/article/10.3389/fnut.2019.00049/full

Similar Items